Stem cell therapy is under active investigation as a novel treatment for feline chronic gingivostomatitis (FCGS), offering hope for cats who do not respond to conventional treatments including full mouth extraction.
Cats with refractory FCGS after full mouth extraction face chronic oral pain with no effective treatment options. Stem cell therapy offers potential welfare benefit for this difficult-to-treat population by providing an immune-modulating mechanism that may resolve the underlying inflammatory process. Progress toward commercially available stem cell treatment represents an important frontier in feline dental welfare.